| Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation A Inazu, ML Brown, CB Hesler, LB Agellon, J Koizumi, K Takata, ... New England Journal of Medicine 323 (18), 1234-1238, 1990 | 1001 | 1990 |
| Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins ML Brown, A Inazu, CB Hesler, LB Agellon, C Mann, ME Whitlock, ... Nature 342 (6248), 448-451, 1989 | 587 | 1989 |
| Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. A Inazu, XC Jiang, T Haraki, K Yagi, N Kamon, J Koizumi, H Mabuchi, ... The Journal of clinical investigation 94 (5), 1872-1882, 1994 | 305 | 1994 |
| Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis Y Noji, K Kajinami, M Kawashiri, Y Todo, T Horita, A Nohara, ... Walter de Gruyter 39 (5), 380-384, 2001 | 224 | 2001 |
| Postprandial lipoprotein metabolism: VLDL vs chylomicrons K Nakajima, T Nakano, Y Tokita, T Nagamine, A Inazu, J Kobayashi, ... Clinica chimica acta 412 (15-16), 1306-1318, 2011 | 203 | 2011 |
| A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer … Y Moriyama, T Okamura, A Inazu, M Doi, H Iso, Y Mouri, Y Ishikawa, ... Preventive medicine 27 (5), 659-667, 1998 | 195 | 1998 |
| Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients H Mabuchi, T Higashikata, M Kawashiri, S Katsuda, M Mizuno, A Nohara, ... Journal of atherosclerosis and thrombosis 12 (2), 111-119, 2005 | 173 | 2005 |
| Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia H Lu, T Higashikata, A Inazu, A Nohara, W Yu, M Shimizu, H Mabuchi Arteriosclerosis, Thrombosis, and Vascular Biology 22 (5), 817-823, 2002 | 142 | 2002 |
| Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia Z Huang, A Inazu, A Nohara, T Higashikata, H Mabuchi Clinical science 103 (6), 587-594, 2002 | 140 | 2002 |
| Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized … H Mabuchi, A Nohara, J Kobayashi, M Kawashiri, S Katsuda, A Inazu, ... Atherosclerosis 195 (2), e182-e189, 2007 | 136 | 2007 |
| Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan H Mabuchi, A Nohara, T Noguchi, J Kobayashi, M Kawashiri, H Tada, ... Atherosclerosis 214 (2), 404-407, 2011 | 127 | 2011 |
| Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency BF Asztalos, KV Horvath, K Kajinami, C Nartsupha, CE Cox, M Batista, ... Journal of lipid research 45 (3), 448-455, 2004 | 119 | 2004 |
| Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle‐aged Japanese R Oka, K Miura, M Sakurai, K Nakamura, K Yagi, S Miyamoto, T Moriuchi, ... Obesity 18 (1), 153-160, 2010 | 114 | 2010 |
| Sitosterolemia, hypercholesterolemia, and coronary artery disease H Tada, A Nohara, A Inazu, N Sakuma, H Mabuchi, M Kawashiri Journal of atherosclerosis and thrombosis 25 (9), 783-789, 2018 | 112 | 2018 |
| Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency J Koizumi, A Inazu, K Yagi, I Koizumi, Y Uno, K Kajinami, S Miyamoto, ... Atherosclerosis 90 (2-3), 189-196, 1991 | 103 | 1991 |
| Comparison of waist circumference with body mass index for predicting abdominal adipose tissue R Oka, K Miura, M Sakurai, K Nakamura, K Yagi, S Miyamoto, T Moriuchi, ... Diabetes research and clinical practice 83 (1), 100-105, 2009 | 98 | 2009 |
| Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation H Mabuchi, A Nohara, T Noguchi, J Kobayashi, M Kawashiri, T Inoue, ... Atherosclerosis 236 (1), 54-61, 2014 | 97 | 2014 |
| Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia Y Noji, T Higashikata, A Inazu, A Nohara, K Ueda, S Miyamoto, ... Atherosclerosis 163 (1), 157-164, 2002 | 94 | 2002 |
| Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors H Mabuchi, A Nohara, A Inazu Molecules and cells 37 (11), 777-784, 2014 | 91 | 2014 |
| Protein-truncating variants at the cholesteryl ester transfer protein gene and risk for coronary heart disease A Nomura, HH Won, AV Khera, F Takeuchi, K Ito, S McCarthy, CA Emdin, ... Circulation research 121 (1), 81-88, 2017 | 89 | 2017 |
Alan R TallMedicine, Columbia UniversityVerified email at cumc.columbia.edu
